STAT Plus: Dana-Farber prevails in immunotherapy dispute over patents behind blockbuster drug
SUZANNE KREITER/THE BOSTON GLOBE
A court ruling will allow Dana-Farber to license the intellectual property behind the patents to companies developing new therapies.
.png)
No hay comentarios:
Publicar un comentario